Structure-activity relationships in fusidic acid-type antibiotics.
D000164:Acremonium / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000494:pharmacology*; D001232:Aspergillus fumigatus / Q000378:metabolism; D001419:Bacteria / Q000187:drug effects; D001426:Bacterial Proteins / Q000096:biosynthesis; D002511:Cephalosporins / Q000096:biosynthesis / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D004352:Drug Resistance, Microbial; D005658:Fungi / Q000187:drug effects; D005672:Fusidic Acid / Q000031:analogs & derivatives / Q000096:biosynthesis / Q000138:chemical synthesis / Q000494:pharmacology*; D003904:Mitosporic Fungi / Q000378:metabolism; D013045:Species Specificity; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D002511:Cephalosporins; D005672:Fusidic Acid